Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Obviously it could go either way. Maybe there's a feeling results ain't good and thus a partnership announcement would help to relief the downward trent, or if result will be good will help to boost it to year highs...who knows...
Personally I believe that this unbelievable delay must have only one reason: having the news (bar or good) close to other news (maybe a partnership?). Who else has the same feeling in here?
I understand what you mean. My optimistic part tells me that perhaps they didn't expect to be off work for so long, so maybe in the meanwhile they just ended up in a situation that went a bit too far and decided to issue this PR to clear things out. My pessimistic part tells me much worse things that I don't even want to imagine. My humoristic part tells me that...maybe someone at the PR office also got the flu and couldn't therefore issue a PR earlier than this? :)
Not what I hope for. I mean, the recent 8k sounds quite unusual to me, but I wouldn't see any reason for it if results weren't finally quite ready to be disclosed. I would expect results no later than next week. Problem is if they will be good or not.
People should also consider that this 8k makes clear that the delay had nothing to do with dreaming dealys related with something about the trial itself...it is only related, as the 8k states, to the fact that people had the flu and thus could not get their hands on the data to elaborate it. This all IMHO.
What I believe is that they now have all of the info but just need to put it together.
I have to admit that I've never seen such an 8k before, seems really new to me and somehow it surprised me.
You seem very optimistic, which is good to know. How do you feel toward the due debt, do you find it fine with you that we didn't hear anything about that yet, or do you expect a news within a couple of days (like I do, btw).
RK, how long, how much are you worried that we didn't hear anything yet?
I wonder...after a company states that it usually takes two weeks and then you turn out not to hear anything for more than a month...what are your thoughts?
I believe the same, mostly because it's fair to think that the majority of placebos chose to cross-over.
Where did Liau say that a large percentage chose not to cross?
Though it is indeed a nice find, I am very surprised no PR has been issued so far, or did I just miss it?
That's what investors have been told ("couple of weeks"), pure and simple.
Series of ifs...anyhow, noone will know, stocks usually get bought out in terms of premium compared to market value/market cap thus a price per share offered in any of those "ifs events", will depend on the amount of OS at that time, which noone can estimate right now. In order for the offer to be accepted, shareholders will have to vote for that (or lend their shares to the bidder), thus, while long time shareholders would want to recoup all or part of their investment, having so many new shareholders at such low prices, will in my opinion "help" to accept a lower price than earlier if a decent offer will ever materialize.
Flipper I hope you understand that in the last months this MB has been flooded with so many posts that probably not even the most important scientists in the world would have been able to, still the stock kept falling and falling and the company diluting and diluting. The only thing needed is facts, and I haven't seen
You sure they will have a PR with median vs and p value? I would only expect the total number evented/PFS at a certain date.
I agree, but that's not what we will get to know shortly, I believe that will take a couple of months.
I am sorry Kabunushi, but you might be missing the point.
There's a PR from the Company that clearly states:
"The Company will have a period of 20 business days, ending in January, within which the Company is obligated to make an offer to repurchase the Notes in accordance with the terms of the indenture relating to the Notes. There is approximately $11.0 million in aggregate principal amount outstanding. The Company believes that it has several options for addressing this obligation, and will be evaluating those options over the coming weeks, although there can be no assurance that such options will be available or will be on acceptable terms. If the Company fails to satisfy its obligation, that would result in an event of default under the Notes."
Then there's a user that posts this message (see post# 90931):
"From the company the 11m is a bond that is renegotiated nothing's due".
So, since I believe the company had no interest and in fact did not post something different than actual facts (contract/debt obligations), why is this user writing something different stating "from the company"?
This is from the 8th DEC's PR:
-----------------------------------
the Company will have a period of 20 business days, ending in January, within which the Company is obligated to make an offer to repurchase the Notes in accordance with the terms of the indenture relating to the Notes. There is approximately $11.0 million in aggregate principal amount outstanding. The Company believes that it has several options for addressing this obligation, and will be evaluating those options over the coming weeks, although there can be no assurance that such options will be available or will be on acceptable terms. If the Company fails to satisfy its obligation, that would result in an event of default under the Notes.
----------------------------------
I wonder where you see the word "renogotiated".
Where did you get the information when you state "from the company"? Who did you talk to?
It's difficult not to agree with you. The P2 news left some people wordless, as many investors didn't even think they would have considered that as a deal. As for NW, I think the same. But what I question myself is, why in the world would you invest more in a company that delisted itself from Nasdaq, sold a hefty stake at 0.35, and had months of silence about the internal investigation? But the most importan question is: what will happen in a couple of months when/if the company will need more money and will have to do another offering at these low prices?
Let's hope they have enough cash to last untill then. If warrants will be all exercised, they will more or less amount for 15M in gross proceeds, minus 11M for debt repurchase there are only 4M left for corporate purpososes and so on. If this is the kind of rises they want to do, the risk is we will be a 200M shares company within next summer or so on.
You call dilution a bit more than 40M in between shares and warrants sold at .35???
I've heard somewhere there were supposed to be multiple PRs...but if this is the kind of PRs we are going to see...
Simply wordless. From 0,9 to 0,4 in a few days and millions of new stock to be sold plus warrants...
At this point, I would personally expect a PR tomorrow, right before the open...
I believe that anything will be done in order to have some kind of info before the meeting, as in my opinion it would be more advisable, therefore I would expect some kind of news very soon. I wonder, though, if it will be the kind of news that shareholders will want to hear. We will see.
I agree that PFS hasn't been reached yet (or just yet), but I didn't have an optimistic feeling after the interview. The timing of the stock to go down is troublesome, and probably the emphasis of the last days of trading on the Nasdaq did the rest. With 11M to be "repurchased" within a short period of time, I believe that many factors in the last few days just didn't go in what I believe would have been the right way.
This is not a good reason to see anyone's investment going so low.
You must be kidding, there's no reason to be happy at all, they need 11M plus the money to run operations within a little bit more than a month. And in the meanwhile no PII partnership with upfront payment has shown up. I would rather be much cautious right now, there's absolutely no reason to cheer.
They can now raise funds through dilution, that means that most likely, given the convertible notes plus the money needed to run operations, in my opinion they will dilute by a huge percentage in the coming month or so.
Actually it seems they were tempted (as for the P.R.), right after the annual meeting, but in my opinion they need immediate cash and they could not wait any longer for another hearing.
I am not a fan of presentations, I don't know why, but the more a comapany makes presentations, the furthest I see partnerships coming in the immediate future. Just my own opinion.
Just my 2 cents on the 2nd of MAY P.R.
http://www.nwbio.com/nw-bio-announces-operations-updates/
1) "The Company has reached conceptual agreement with three different sets of parties, in regard to three different combination treatments, for three different cancers in three different Phase II trials. These involve leading participants in the immunotherapy field. The Company and these parties are now completing the agreements and budgets, and pursuing regulatory approval for the agreed upon trials."
It doesn't specify if the PII where for Direct or for L, so it's safe to assume if was for DCVAX as a whole. The problem I see is that if the one just announced is the type of agreements they are trying to pursue, then I see much space for worries, as it did not include any upfront payment. I personally interpreted it as a mild interest by other companies.
2) "The Company’s Phase III trial of DCVax-L for GBM brain cancer is ongoing. As previously announced, well over 300 patients have been enrolled in the trial and the patients are continuing to be treated in accordance with the trial protocol. The trial remains subject to a partial clinical hold on screening of additional patient candidates. The Company is in ongoing dialog with regulators, and providing further information. The Company hopes that this issue will be resolved soon."
Personally it didn't seem to me this part of the P.R. was positive. It seems that there indeed was an issue on which the regulators asked for more info and they provided further information. However shareholders have never been advised on if this dialog brought to something or solved partially or totally the issue.
I am personally convinced (and this is my own opinion) that it has something to do with the fact that "everybody is living longer", and that perhaps regulators asked for some further information on recruiting criteria, thus the partial hold on that side.
Moffitt Cancer Center
Tampa, Florida, United States, 33612
listed on clinicaltrials.gov
https://www.clinicaltrials.gov/ct2/show/study/NCT00045968?term=gbm&rank=7&show_locs=Y#locn
So if I understood it well, you mean that since she knows it and she has been recently honored, then she probably was honored for how the trial was progressing though noone knows this publicly? Did I understand this correctly or am I wrong?
I see, so you mean noone ever said that the fact that patients were living longer, which was a good thing, wasn't though helping the trial?!? Uhm...
So you mean the trial isn't indeed blinded?
I agree with your view. I think that even PRs on what they are exactly at right now with the L trial would be more than welcomed.
So did "these" people that seem to know so much more than the market stepped in and bought huge amounts of shares?
Nice job.